• / Free eNewsletters & Magazine
  • / My Account
Home>Novartis psoriasis drug approved in Japan

Novartis psoriasis drug approved in Japan

3party Content

Fri, 26 Dec 2014

By Marta Falconi ZURICH--Swiss pharmaceutical company Novartis AG said Friday that it won approval in Japan for a new psoriasis drug, the first country to give the treatment a green light for commercialization. Novartis said secukinumab, marketed as Cosentyx, is approved in the country to treat
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.